Table 3. HSV-2 seroprevalence by HIV seroprevalence and by gender among never-injecting drug users, New York City, 1995–1999 and 2005–2011.
1995–1999 | 2005–2011 | |
n+/N (%) | n+/N (%) | |
HIV negatives total | 91/159 (57)# | 857/1527 (56)# |
HIV negative males | 30/79 (38)* | 572/1183 (48)* |
HIV negative females | 61/80 (76)* | 285/344 (83)* |
HIV positives total | 30/37 (81)# | 190/237 (80)# |
HIV positive males | 11/17 (65)* | 99/144 (67)* |
HIV positive females | 19/20 (95)* | 91/93 (98)* |
Significant differences for males vs. females by chi-square test.
Significant differences for HIV seropositives vs. HIV seronegatives by chi-square test.